Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 240 for “"Pre-eclampsia"”.
-
Screening Programme for Pre-eclampsia
Background <br/>Pre-eclampsia (PE) is a hypertensive disorder complicating 2–8% of all pregnancies and is a major cause of perinatal morbidity and mortality. The majority of women with PE present clinically near term with favourable maternal and neonatal outcomes; however, a subset of women …
-
Inflammatory Mediators Associated with Pre-eclampsia
PURPOSE: Pre-eclampsia, a hypertensive disorder unique in pregnancy, complicates approximately 5-7 % of pregnancies and is a leading cause of intrauterine fetal growth retardation, premature delivery, and maternal death. It is characterized by proteinuria, edema, platelet aggregation, and increased …
-
Gestational hypertension - common pathways with pre-eclampsia
abstract is not provided.
-
The PIERS (Pre-eclampsia Integrated Estimate of RiSk) model : development of a valid outcome prediction model for pre-eclampsia.
… of maternal risk by developing a model - the Pre-eclampsia Integrated Estimate of RiSk (or PIERS) model – that predicts a combined adverse maternal outcome (mortality and/or significant morbidities) within 48 hour of, and up to seven days after, admission with pre-eclampsia (study …
-
Genetic determinants of pre-eclampsia: HLA-G and KIR2DL4 alleles/haplotypes and risk of pre-eclampsia in a malay population
Pre-eclampsia (PE) is a leading cause of maternal and fetal mortality andmorbidity. HLA-G is expressed predominantly on fetal extravillous trophoblasts thatinvade the maternal decidua during pregnancy and has been postulated to beimportant in the maintenance of a healthy pregnancy. It has been …
-
The role of nitric oxide in pre-eclampsia
Hypertension complicates approximately 10% of all pregnancies and is a leading cause of maternal and foetal mortality and morbidity world-wide. Pre-eclampsia is a major subgroup of these hypertensive disorders. It is defined as a rise in blood pressure to 140/90mm Hg or greater accompanied by …
-
Pre-eclampsia: early prediction and long-term consequences
Approximately one in ten pregnant women will have their blood pressure recorded above normal at some point during their pregnancy. Pre-eclampsia, the most common hypertensive disorder of pregnancy, affects around 5% of all first time mothers, and is an important cause of foetal and maternal …
-
A study of coagulation potential in pre-eclampsia
Pre-eclampsia is a multisystem obstetric disease of unknown aetiology that is associated with enhanced coagulation, endothelial activation and reduced placental function. A two-stage model for pre-eclampsia has been proposed involving abnormal placentation and the maternal response to this. In this …
-
Validity of Administrative Database for Reporting Pre-eclampsia
Background: Pre-eclampsia (PET) is one of the major causes of maternal and neonatal morbidity and mortality1. Misclassification of PET can lead to biased or erroneous results in epidemiologic studies resulting in false conclusions. Objectives: The objectives of this thesis are to determine the …
-
The prediction of adverse maternal outcomes in pre-eclampsia
Pre-eclampsia (PET) continues to contribute to maternal and perinatal morbidity and mortality. Management decisions include an evaluation of maternal risk, which is assisted by expert opinion-based guidelines, while not accounting for gestational age (GA) at diagnosis. We evaluated the feasibility …
-
The maternal predisposition to the syndrome of pre-eclampsia
Pre-eclampsia, which is characterized by maternal hypertension, proteinuria, hypoperfusion of end organs and a systemic maternal innate inflammatory response, is a leading cause of maternal mortality and morbidity world-wide. When of early-onset, pre-eclampsia is associated with fetal intrauterine …
-
STUDY ON COAGULATION AND FIBRINOLYTIC SYSTEMS IN PRE-ECLAMPSIA AND THE SHORT TERM EFFECTS OF METHYLDOPA AND ISRADIPINE ON HAEMOSTATIC MECHANISMS IN PRE-ECLAMPSIA
… fibrinogen and beta-thromboglobulin were seen in preeclampsia compared to normal pregnancy when matched for age and gestation. The reduced plasma u-PA and PAI-2 levels indicate reduced synthesis by the placenta with less available t-PA activity in the circulation. Raised t-PA antigen reflects …
-
Markers of Cardiovascular Dysfunction After Pregnancies Complicated by Pre-Eclampsia
Pre-eclampsia (PE) is a hypertensive disorder of pregnancy characterized by maternal systemic endothelial dysfunction. While the clinical manifestations resolve soon after delivery, a large body of epidemiological evidence indicates significant long-term maternal risk for cardiovascular disease …
-
Pre-Eclampsia: Renal and Hepatic Factors in Relation to Proteins
Abstract Not Provided.
-
Vascular damage in pre-eclampsia: the role of endothelial dysfunction
Pre-eclampsia is a multisystem disorder specific to pregnant women and is the major cause of maternal death in the United Kingdom today. The common pathophysiological feature of virtually all manifestations of pre-eclampsia is vascular endothelial dysfunction. This probably results from poor …
-
The role of the paraoxonases in pre-eclampsia and labour
… labour, the hypothesis was that placental PON2 expression would alter during labour. PON2 was examined in placentas obtained from women who delivered by caesarean section and were not in labour and compared to the equivalent zone of placentas obtained from women who delivered vaginally following …
-
Quantification of the glycocalyx in the study of pre-eclampsia
Introduction: Pre-eclampsia is a multisystem disorder of pregnancy characterised by widespread endothelial dysfunction. The glycocalyx is present at the luminal surface of endothelial cells and at the maternal-fetal interface of the placenta. It has important roles in maintaining normal endothelial …
-
Vascular biology in the menstrual cycle, pregnancy and pre-eclampsia
… causes of maternal death in the United Kingdom. Pre-eclampsia is associated with increase in immediate and lifetime risk of adverse thrombotic events. Both pregnancy and the follicular phase are associated with arterial thrombosis and myocardial infarction. Modulation of haemostatic mechanisms in …
-
Epidemiological and genetic approaches to explore risk factors for pre-eclampsia
Problem: Pre-eclampsia (PE) is a pregnancy complication that occurs in 3-10% of pregnancies world-wide, and it is characterized by high blood pressure and proteinuria. HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelets syndrome) is a form of severe PE. Both environmental and genetic …
-
Recombinant human activated protein C as a therapy for pre-eclampsia
INTRODUCTION: Pre-eclampsia remains one of the most common causes of maternal mortality in the developed world, and we still have no known effective prophylaxis and proven modifiers. The recent successful clinical trial of recombinant human activated protein C (rhAPC) in the management of SIRS …
Page 1 of 12